ETFsBloomberg MSCI ESG Global Corporate 1-5 Year Select Index
Amundi

Amundi Global Corporate Bond 1-5Y ESG UCITS ETF Acc

UBBB PAAccumulatingPhysical, full replicationLuxembourgNot PEA-eligible
Last close · EUR
55.94EUR
-0.32% · -€0.18
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
UBBBBase
Fund charges
0.20%Total expense ratio (TER)
Fund size
€583.4Mall share classes
Return 1Y
+3.3%
Sharpe 3Y
0.20
Volatility 1Y
4.1%annualised
Holdings
4,626Fund holdings

Performance

Compare
  • UBBB+3.3%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
UBBB+1.0%+1.9%+3.1%+3.9%+3.3%+11.3%+10.4%
MSCI World-2.8%-0.6%+7.8%+14.3%+14.1%+65.6%+64.8%
Gap to MSCI World+3.8%+2.5%-4.7%-10.4%-10.8%-54.3%-54.5%

Risk and return

Sharpe ratio · 3Y
0.20
Below MSCI World · 1.24
Return p.a.
+3.6%
Volatility
4.5%
Max loss
-6.3%Jul 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
UBBB
0.20
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
1.0%
Holdings
4,626
As of
Fund holdings
  1. 1SKYDANCE CORP 7.05% Oct31US69932AAT250.13%
  2. 2BANK OF AMER VAR Dec28US06051GHD430.11%
  3. 3WELLS FARGO C VAR Apr31US95000U3W120.10%
  4. 4AMAZON.COM IN 4.25% Mar31US023135DD510.09%
  5. 5NTT FINANCE 0.967% Jun29JP316572BQ620.09%
  6. 6ABBVIE INC 3.2% Nov29US00287YBX670.09%
  7. 7GOLDMAN SACHS VAR Jan29US38145GAP540.09%
  8. 8NVIDIA CORP 4.5% Jun31US67066GAR560.08%
  9. 9SALESFORCE IN 4.65% Mar29US79466LAR500.08%
  10. 10MORGAN STANLE 3.591% Jul28US61744YAK470.08%

Countries

Classified 98.6%
Largest
46.1%United States
Top 3
61.9%
Effective number
4.21 / HHI

Market cap

Weight vs holdings

1.0%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.